🕵️ Indaptus Therapeutics, Inc. ($INDP)
SEC insider & ownership activity, last 12 months · CIK 1857044 · every row links its SEC filing
Insiders were quiet over the last 12 months – no open-market buys or sells. David E. Lazar trimmed 98.0% → 47.9%; Yao Yun trimmed 37.1% → 31.5%. No red-flag 8-Ks in the window.
Insider flow
0 buyers, $0 (0 lots) · 1 seller, $0 (2 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| David E. Lazar | 0 | – | 2 | – | Mar 23, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| David E. Lazar | 47.9% | 13D | Mar 23, 2026 | filing ↗ | |
| Xu Chenhao | 34.3% | 13D | Apr 28, 2026 | filing ↗ | |
| Yao Yun | 31.5% | 13D | Jun 24, 2026 | filing ↗ | |
| Chenhao Xu | 29.2% | 13D | Jun 24, 2026 | filing ↗ | |
| SINO LION Ventures Ltd | 29.2% | 13D | Jun 24, 2026 | filing ↗ | |
| Jeffery A. Meckler | 12.7% | 13D | Dec 22, 2025 | filing ↗ | |
| Dai Junyi | 8.4% | 13D | Jun 24, 2026 | filing ↗ | |
| Yang Ting | 8.4% | 13D | Jun 24, 2026 | filing ↗ | |
| Newman Michael James | 5.4% | 13D | Dec 22, 2025 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Material agreement (1.01) | Jun 17, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Jun 17, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 17, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jun 1, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 1, 2026 | filing ↗ |
| Earnings (2.02) | May 15, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 15, 2026 | filing ↗ |
| Officer/director changes (5.02) | Apr 22, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 22, 2026 | filing ↗ |
| Officer/director changes (5.02) | Apr 22, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 22, 2026 | filing ↗ |
| Officer/director changes (5.02) | Mar 31, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 31, 2026 | filing ↗ |
| Change of control (5.01) | Mar 18, 2026 | filing ↗ |
| Officer/director changes (5.02) | Mar 18, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 18, 2026 | filing ↗ |
| Material Modifications to Rights of Security Holders (3.03) | Feb 26, 2026 | filing ↗ |
| Change of control (5.01) | Feb 26, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | Feb 26, 2026 | filing ↗ |
| Shareholder vote (5.07) | Feb 26, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 26, 2026 | filing ↗ |
| Material agreement (1.01) | Feb 11, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Feb 11, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 11, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jan 20, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 20, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jan 8, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 8, 2026 | filing ↗ |
| Officer/director changes (5.02) | Dec 29, 2025 | filing ↗ |
| Material agreement (1.01) | Dec 22, 2025 | filing ↗ |